Form 144 LIGAND PHARMACEUTICALS INCORPORATED For: 23 March
#Form 144 #Ligand Pharmaceuticals #SEC filing #restricted securities #insider transaction #March 23 #regulatory disclosure
π Key Takeaways
- A Form 144 filing was submitted for Ligand Pharmaceuticals Incorporated.
- The filing date is specified as March 23.
- Form 144 indicates a potential intent to sell restricted securities.
- This is a routine regulatory disclosure for company insiders or affiliates.
π·οΈ Themes
Regulatory Filing, Pharmaceuticals
Entity Intersection Graph
No entity connections available yet for this article.